Raymond James sets USD 150.00 target for Encompass Health stock

Published on 10/20/2026 at 18:55 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 9.60 percent in 2026. Encompass Health stock costs EUR 107.50 on October 20, 2026, 17.28 percent below its high.

Analyst target and reporting date

Raymond James set a USD 150.00 target for Encompass Health on September 28, 2026.
Second-quarter 2026 revenue rose 9.60 percent year over year to USD 1.60 billion.
Encompass Health stock costs EUR 107.50 at Lang & Schwarz on October 20, 2026 at 6:44 p.m. CEST, 17.28 percent below its 52-week high.
Encompass Health will report third-quarter results after the market closes on October 28, 2026.

EHC, US29261A1007, Illustration mit AI erstellt.

Raymond James set a USD 150.00 target for Encompass Health stock in a report dated September 28, 2026, according to MarketBeat. Against the USD 120.59 NYSE price on October 20, 2026 at 12:53 p.m. ET, the target is 24.39 percent above the share price. Encompass Health stock was trading at EUR 107.50 at Lang & Schwarz on October 20, 2026 at 6:44 p.m. CEST.

Second-quarter growth sets the baseline

The latest reported quarter delivered a measurable operating step-up. Encompass Health reported second-quarter 2026 net operating revenue of USD 1.60 billion on August 5, 2026, up 9.60 percent from USD 1.46 billion in the second quarter of 2025. Adjusted earnings per share increased to USD 1.55 from USD 1.40, while adjusted EBITDA rose to USD 348.00 million from USD 318.60 million.

The company also increased its full-year 2026 outlook in that release. Adjusted earnings per share guidance moved to USD 6.02-6.25 from USD 5.89-6.11, and adjusted EBITDA guidance moved to USD 1.365-1.395 billion from USD 1.350-1.380 billion.

Stock sits below its yearly high

The NYSE quote of USD 120.59 on October 20, 2026 at 12:53 p.m. ET places the stock between its 52-week low of USD 92.77 and high of USD 129.96. The current price is 7.21 percent below that high and 29.99 percent above the low. Encompass Health had a market capitalization of USD 11.9 billion on October 20, 2026.

What comes with the next report?

Encompass Health announced on October 1, 2026 that it will report third-quarter results after the market closes on October 28, 2026. The company scheduled its earnings call for October 29, 2026 at 10:00 a.m. ET. The report will cover the quarter ended September 30, 2026.

For investors, the key comparison is whether the next quarter can sustain the second-quarter pattern of 9.60 percent revenue growth and adjusted EBITDA growth of 9.20 percent. The existing guidance range gives the market a defined benchmark for adjusted earnings per share of USD 6.02-6.25 in fiscal year 2026.

Price and reporting date

Encompass Health operates inpatient rehabilitation hospitals across the United States. Its 177 hospitals in 39 states and Puerto Rico provide the operating base behind the revenue and capacity figures reported for the second quarter.

The further course of trading is shown by the continuously updated real-time quote of Encompass Health stock.